G

Genenta Science SpA
D

GNTA

5.63000
USD
0.84
(17.54%)
مغلق
حجم التداول
323
الربح لكل سهم
-1
العائد الربحي
-
P/E
-11
حجم السوق
102,971,946
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABCL
    -0.11000
    (-3.99%)
    2.65000 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EXAS
    -1.680
    (-3.29%)
    49.330 USD
    G
    GH
    -1.065
    (-3.53%)
    29.130 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.830 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    T
    TDOC
    0.23500
    (2.62%)
    9.19500 USD
    المزيد
الأخبار

العنوان: Genenta Science SpA

القطاع: Healthcare
الصناعة: Biotechnology
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.